mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.04 |